Title : Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients.

Pub. Date : 2017 Dec

PMID : 29456473






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 T-DM1 combines the anti-tumor activity of trastuzumab with that of DM1, a highly potent derivative of the anti-microtubule agent maytansine, resulting in increased anti-tumor activity. Maytansine DM1 protein kinase Homo sapiens
2 T-DM1 combines the anti-tumor activity of trastuzumab with that of DM1, a highly potent derivative of the anti-microtubule agent maytansine, resulting in increased anti-tumor activity. Maytansine DM1 protein kinase Homo sapiens